Safety and efficacy of insulin detemir basal-bolus therapy in type 1 diabetes patients: 14-week data from the European cohort of the PREDICTIVE study

By Dornhorst Anne   Lüddeke Hans-Joachim   Honka Marek   Ackermann Ralf W.   Meriläinen Markus   Gallwitz Baptist   Sreenan Seamus    

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 369-376

Informa Healthcare

Access to resources Recommend Favorite

An economic assessment of analogue basal–bolus insulin versus human basal–bolus insulin in subjects with type 1 diabetes in the UK

By Palmer Andrew J.   Valentine William J.   Ray Joshua A.   Foos Volker   Lurati Francesco   Smith Inger   Lammert Morten   Roze Stéphane  

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 895-901

Informa Healthcare

Access to resources Recommend Favorite

The glycemic efficacies of insulin analogue regimens according to baseline glycemic status in Korean patients with type 2 diabetes: sub‐analysis from the A1chieve® study

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 68, Iss. 11, 2014-11 ,pp. : 1338-1344

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effectiveness of insulin initiation regimens in patients with type 2 diabetes mellitus: a large national medical records review study comparing a basal insulin analogue to premixed insulin

By Sun Peter   Wang Ruoping   Jacober Scott  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 3017-3023

Informa Healthcare

Access to resources Recommend Favorite

Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy

By Abrahamson Martin J.   Peters Anne  

Annals of Medicine, Vol. 44, Iss. 8, 2012-12 ,pp. : 836-846

Informa Healthcare

Access to resources Recommend Favorite